Trials / Withdrawn
WithdrawnNCT04240080
Impact of Near-Infrared Vein Mapping on Outcomes and Satisfaction After Botox/Filler Treatment
The Impact of Near-Infrared Vein Mapping on Outcomes and Satisfaction After Botox/Filler Treatment
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Researchers are studying how vein mapping impacts patient outcomes and satisfaction after facial injection procedures.
Detailed description
Facial Botox/filler injections carry risk of puncturing superficial veins, leading to bruising and pain. Our study will investigate the utility of non-invasive vein imaging (specifically near-infrared light reflection) on the incidence of pain/bruising/hematoma and patient satisfaction after facial injections. The current standard of care for facial injection procedures does not involve any modality of facial venous mapping. Vein mapping is a non-invasive, simple task that takes very little time to conduct. One risk is patient time, however maximum extra time needed will be 5 minutes during the clinical visit. This potential extra time in mind, the benefits far outweigh the risks. Two cohorts of patients will be prospectively compared following randomization, those who did have pre-procedure venous mapping prior to injection versus those who did not. Data will be analyzed with regard to bruising and swelling following injection, as well as other potential complications such as hematoma or infection, along with patient satisfaction survey information.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Accuvein® Veinfinder | Near-infrared light reflection utilized by healthcare providers to see superficial veins under the skin. |
Timeline
- Start date
- 2020-01-10
- Primary completion
- 2024-12-01
- Completion
- 2024-12-01
- First posted
- 2020-01-27
- Last updated
- 2024-05-01
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04240080. Inclusion in this directory is not an endorsement.